Novartis AG (BCBA:NVS)

Market Cap	307.51T
Revenue (ttm)	65.77T
Net Income (ttm)	16.27T
Shares Out	n/a
EPS (ttm)	8,163.07
PE Ratio	18.90
Forward PE	14.30
Dividend	624.65 (1.61%)
Ex-Dividend Date	Mar 12, 2025

Volume	8
Average Volume	385
Open	38,650
Previous Close	38,575
Day's Range	38,650 - 38,925
52-Week Range	26,525 - 40,500
Beta	n/a
RSI	63.45
Earnings Date	Jul 17, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD